Competitive Enterprise Institute
FDANonrulemakingFDA-2025-N-1557

Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments

RIN
Last modified
Aug 15, 2025
Comment window
closed 377d ago
Competitive Enterprise Institute filings
1

Activity

Competitive Enterprise Institute filed 1 comment on this docket between Aug 15, 2025 and Aug 15, 2025. 17 other organizations filed here. The comment window closed 377d ago.

What Competitive Enterprise Institute filed (1)

Aug 15, 2025· Comment from Competitive Enterprise Institute· FDA-2025-N-1557-3988

Filed on regulations.gov — full text not in the inline record.

Abstract

OPEN

View on regulations.gov →
Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments (FDA) — Competitive Enterprise Institute | OpenPolis